COMMUNIQUÉS West-GlobeNewswire

Addressing Mental Health Disparities for Minorities
26/08/2026
San Diego-based Park Mental Health experts highlight barriers to treatment for historically underserved communities and the importance of equality through culturally responsive care San Diego, CA., Aug. 26, 2026 (GLOBE [...]
NeOnc’s Clinical Story Is Now the Main Event
26/08/2026
DENVER, Aug. 26, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings (NASDAQ: NTHI) has reached a point where the market conversation can move toward a much more consequential question: What happens if NEO100’s [...]
Oddifact and Mabion Receive FDA Pre-IND Meeting Grant for RTX-NP (MabionCD20) in Immune Thrombocytopenia
26/08/2026
FDA grants Type B pre-IND meeting, enabling critical alignment with the Agency on the development strategy for RTX-NP Oddifact and Mabion aim to bring rituximab's well-established activity in ITP to formal FDA approval [...]
Is Walking Your Dog Enough?
26/08/2026
MYOS PET Veterinary Adviser Answers Four Common Questions About Keeping Dogs Healthy and Strong CEDAR KNOLLS, N.J., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Think a daily walk is enough to keep your dog fit? Not necessarily. [...]
Inspire Medical Systems, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference
26/08/2026
MINNEAPOLIS, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive [...]
Nucleus and Legacy Partner to Help Families Decide If IVF is Right for Them
26/08/2026
The partnership connects advanced genetic and male fertility testing, giving prospective parents more information to guide their next steps for family planning. NEW YORK, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Nucleus [...]
Philips selected for ARPA-H program to advance AI-enabled robotic stroke care
26/08/2026
August 26, 2026 Philips receives up to US$33.7 million award from ARPA-H to expand access to AI-enabled robotic stroke care, supporting the program's goal of expanding access to specialized interventions Philips will [...]
Milestone Scientific Achieves Debt-Free Balance Sheet Through Debt-to-Equity Conversion by Three Directors
26/08/2026
Conversion of $465,000 in Debt Strengthens Stockholders’ Equity and Further Aligns Directors with Shareholders ROSELAND, N.J., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (MLSS), a leading developer of [...]
Legato Emerges from Stealth with $12 Million in Funding to Pioneer a New Era of Hearing Devices with AI-Powered Hearing Glasses
26/08/2026
Poised to shake up the $15B global hearing device market with new technology that blends performance with design, Legato will debut its first product, Legato Frames, in the coming months BOSTON, Aug. 26, 2026 (GLOBE [...]
Femasys Partners with UNC Health to Introduce Its FemaSeed® Fertility Portfolio Across Statewide OB/GYN Care Locations
26/08/2026
-- For the first time, OB/GYNs within the UNC Health system will be able to offer women FemVue ® fertility evaluation and FemaSeed as a first-line treatment option -- ATLANTA, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Femasys [...]
9/11 Anniversary Nears and the Health Effects Are Still Emerging 25 Years Later
26/08/2026
World Trade Center Health Program Urges Those Exposed to 9/11 Toxins as Children or Young Adults to Learn Whether They Qualify for Specialized Care NEW YORK, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Twenty-five years after the [...]
Daré Bioscience’s Sildenafil Cream Data in Postmenopausal Women Published in Menopause - The Journal of The Menopause Society
26/08/2026
Daré’s proprietary formulation of topical sildenafil cream, 3.6% was well tolerated across all evaluated doses in the clinical study, with minimal systemic exposure Company continues activities necessary to advance its [...]
Prenetics’ IM8 CEO and CFO Purchase $1.0 Million of Shares in the Open Market Following Second Quarter Results
26/08/2026
Cumulative Personal Investment by Leadership Since November 2025 Reaches Approximately $3.75 Million NEW YORK, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a [...]
SciSparc Advances Agentic AI Strategy with Addition of Internationally Recognized AI Expert Prof. Carmel Domshlak to Scientific Advisory Board
26/08/2026
The addition of leading AI researcher further strengthens SciSparc’s scientific and technical foundation as the Company advances its strategic focus on the Agentic AI market TEL AVIV, Israel, Aug. 26, 2026 (GLOBE [...]
20/20 BioLabs to Host Investor Webinar on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity
26/08/2026
CEO Jonathan Cohen to Detail the Company’s Strongest Quarterly Performance Since Commercial Launch of Multi-Cancer Early Detection Testing, Key Takeaways from the Next Generation Dx Summit, and Path to Broader [...]
Autonomix Medical Expands Intellectual Property Portfolio with New U.S. Patent Covering Feedback-Guided Precision Neuromodulation and Targeted Therapy Delivery
26/08/2026
New patent broadens protection around systems integrating real-time physiological feedback, sensing and imaging with controlled therapeutic delivery, including neural ablation approaches for cancer pain THE WOODLANDS, [...]
Celcuity Submits sNDA to FDA for REVTORPYK™ (gedatolisib) for HR+/HER2-, PIK3CA Mutant Locally Advanced or Metastatic Breast Cancer
26/08/2026
If approved, REVTORPYK would be the first and only therapy for advanced breast cancer with a PIK3CA mutation that inhibits all class I PI3K isoforms (α, β, δ, γ) and mTOR complexes mTORC1 and mTORC2 MINNEAPOLIS, Aug. 26 [...]
NOMAD Power Solutions, Inc. Receives DOE Authorization to Advance Vermont Long-Duration Energy Storage Project into Phase 3
26/08/2026
Installation phase will deploy NOMAD’s transportable battery energy storage technology at sites within Green Mountain Power’s service territory BOCA RATON, Fla., Aug. 26, 2026 (GLOBE NEWSWIRE) -- NOMAD Power Solutions, [...]
IMUNON to Host 2026 R&D Day Highlighting Phase 3 OVATION 3 Trial and the Clinical Potential of IMNN-001
26/08/2026
Leading oncology experts and company management will discuss the Phase 3 OVATION 3 study, supporting science and data, clinical progress, and upcoming milestones A patient treated with IMNN-001 will share firsthand [...]

Pages